June 23, 2026 · Gynecologic oncology · DOI: 10.1016/j.ygyno.2026.06.012

Diagnostic value of FAM19A4/SOX1/PAX1 methylation in non-16/18 high-risk HPV cervical lesions

Listen to this summary

The authors aimed to evaluate the diagnostic performance of FAM19A4, SOX1, and PAX1 methylation testing as a triage method for women aged 30 and older with positive non-16/18 high-risk HPV. Their findings indicate that this methylation testing not only correlates with the severity of cervical intraepithelial neoplasia (CIN) but also offers higher specificity and comparable sensitivity compared to traditional cytology, potentially reducing unnecessary colposcopy referrals and improving management strategies for these patients.

Peiyu Feng, Keyi Shi, Wei Zhao, Jijun Zhang, Xiao Chen, Jun Zhu, Gang Chen, Zhiqi Wang, Xin Zhou, Feng Zhou, Xiaodong Cheng, Yang Li

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play